(Q35600457)

9 August 2017

title

Folate improves endothelial function in patients with coronary heart disease (English)

1 reference

9 August 2017

0 references

1 reference

coronary artery disease

1 reference

3

Stuart Moat

1 reference

9 August 2017

5

Jonathan Goodfellow

1 reference

9 August 2017

Sagar Doshi

1

1 reference

9 August 2017

Ian McDowell

series ordinal

2

1 reference

9 August 2017

Malcolm Lewis

series ordinal

4

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Clinical Chemistry and Laboratory Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

41

1 reference

9 August 2017

issue

11

1 reference

9 August 2017

page(s)

1505-1512

1 reference

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Folic acid--an innocuous means to reduce plasma homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Putative mechanisms for vascular damage by homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Oxidative stress and endothelial nitric oxide bioactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

The oxidation hypothesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

The natural history of vascular disease in homocystinuria and the effects of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Regulatory functions of the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

The generation of nitric oxide by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Some metabolic relationships between biopterin and folate: Implications for the ?methyl trap hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Endothelial nitric oxide synthase interactions with G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

Exercise training enhances endothelial function in young men

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.231

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.231

1 reference

9 August 2017

1 reference